Back
Speaker illustration

undefined undefined undefined

Presentations

Cognitive function and adherence to treatment in patients with chronic heart failure and reduced left ventricular ejection fraction: relation and prognostic meaning

Event: ESC Congress 2019

Topic: Comorbidities

Session: Heart failure: aspects of aging and cognition

Access
Like
Thumbnail

New disease-specific adherence questionnaire can predict 2-year survival in chronic heart failure

Event: ESC Congress 2019

Topic: Comorbidities

Session: Heart failure management

Access
Like
Thumbnail

Prognostic value of cognitive tests in chronic heart failure with reduced left ventricular ejection fraction

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Access
Like
Thumbnail

Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Access
Like
Thumbnail

Meldonium and gamma-butyrobetaine combination improves cognitive function and flow-mediated vasodilatory response in chronic systolic heart failure: the results of open-label pilot study.

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access
Like
Thumbnail

Cognitively impaired versus cognitively non-impaired chronic heart failure patients: which distinctions?

Event: Heart Failure 2018

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources